🇺🇸 FDA
Patent

US 11389400

Aerosilization of stem cells or stem cell derivatives for pulmonary delivery

granted A61KA61K35/28A61K35/50

Quick answer

US patent 11389400 (Aerosilization of stem cells or stem cell derivatives for pulmonary delivery) held by The Government of the United States, as represented by the Secretary of the Army expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States, as represented by the Secretary of the Army
Grant date
Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K35/28, A61K35/50, A61K35/545, A61K9/0075